Tag: Kazia Therapeutics
Kazia Therapeutics: Raises $4.5m and launches SPP
Kazia Therapeutics Raises $4.5m and launches SPPKazia Therapeutics (KZA) launches $4.5 million via a placement to drive its...
Kazia Therapeutics: Partners with DFCI to treat rare lymphoma
Cancer treatment specialist Kazia Therapeutics (KZA) is teaming up with the U.S. Dana-Farber Cancer Institute (DFCI) to treat...
Kazia Therapeutics: Closes $1.8M share purchase plan
Kazia Therapeutics: Closes $1.8M share purchase planBiotech company Kazia Therapeutics (KZA) has closed its $1.8M share purchase plan
...
Kazia Therapeutics: Completes recruitment for ongoing paxalisib phase 2 study
Kazia Therapeutics: Completes recruitment for ongoing paxalisib phase 2 studyKazia Therapeutics has also completed the recruitment stage for...